van de Vijver MJ - Search Results

1

Ductal carcinoma in situ of the breast: histological classification and genetic alterations.

van de Vijver MJ. van de Vijver MJ. Recent Results Cancer Res. 1998;152:123-34. doi: 10.1007/978-3-642-45769-2_11. Recent Results Cancer Res. 1998. PMID: 9928552 Review.

2

Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.

Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FB, Devilee P, Cornelisse CJ, van de Vijver MJ, Mooi WJ, et al. Schuuring E, et al. Among authors: van de vijver mj, van tinteren h. Cancer Res. 1992 Oct 1;52(19):5229-34. Cancer Res. 1992. PMID: 1394126

3

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R. van de Vijver MJ, et al. N Engl J Med. 1988 Nov 10;319(19):1239-45. doi: 10.1056/NEJM198811103191902. N Engl J Med. 1988. PMID: 2903446

4

Ductal carcinoma in situ: a proposal for a new classification.

Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B. Holland R, et al. Among authors: van de vijver mj. Semin Diagn Pathol. 1994 Aug;11(3):167-80. Semin Diagn Pathol. 1994. PMID: 7831528 Review.

5

Recent developments in the molecular genetic understanding of breast cancer.

Devilee P, Schuuring E, van de Vijver MJ, Cornelisse CJ. Devilee P, et al. Among authors: van de vijver mj. Crit Rev Oncog. 1994;5(2-3):247-70. doi: 10.1615/critrevoncog.v5.i2-3.70. Crit Rev Oncog. 1994. PMID: 7849087 Review.

6

Molecular genetic changes in human breast cancer.

van de Vijver MJ. van de Vijver MJ. Adv Cancer Res. 1993;61:25-56. doi: 10.1016/s0065-230x(08)60954-9. Adv Cancer Res. 1993. PMID: 8346719 Review. No abstract available.

7

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.

Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ. Vos CB, et al. Among authors: van roy f, de leeuw wj, van de vijver mj. Br J Cancer. 1997;76(9):1131-3. doi: 10.1038/bjc.1997.523. Br J Cancer. 1997. PMID: 9365159 Free PMC article.

8

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.

De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM. De Leeuw WJ, et al. Among authors: van roy f, van de vijver mj. J Pathol. 1997 Dec;183(4):404-11. doi: 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9. J Pathol. 1997. PMID: 9496256

9

Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast.

Vos CB, Ter Haar NT, Peterse JL, Cornelisse CJ, van de Vijver MJ. Vos CB, et al. Among authors: van de vijver mj. J Pathol. 1999 Feb;187(3):279-84. doi: 10.1002/(SICI)1096-9896(199902)187:3<279::AID-PATH240>3.0.CO;2-C. J Pathol. 1999. PMID: 10398079

10

Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression.

Elkhuizen PH, Voogd AC, van den Broek LC, Tan IT, van Houwelingen HC, Leer JW, van de Vijver MJ. Elkhuizen PH, et al. Among authors: van houwelingen hc, van de vijver mj, van den broek lc. Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):73-83. doi: 10.1016/s0360-3016(99)00158-3. Int J Radiat Oncol Biol Phys. 1999. PMID: 10477009 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters